The outbreak, which was widely covered in the media, caused concern amongst cat owners.
The findings of an investigation found a link between high concentrations of trichothecene T-2/HT-2 mycotoxins (both poisonous substances, produced by fungi) in certain cat foods.
The first study, published in the Journal of Veterinary Internal Medicine, describes 580 cats recorded by the RVC’s database during the initial outbreak, the epidemiology of the cases and the link with mycotoxin exposure.
The cats presented with severe reductions in vital blood cells, including white blood cells responsible for fighting infection and platelets responsible for blood clotting.
The research recounts how analysis of these cats’ data – provided both by pet owners and vets - revealed three diets that had been consumed by the majority of affected cats and how this subsequently led to a UK wide recall in June 2021.
Examining the subsequent analysis of the feed samples and the discovery of mycotoxin contamination, which is known to be toxic to bone marrow, and thereby negatively impacting the production of key blood cells, the study concludes that mycotoxin contamination should be considered as the cause of the outbreak.
The second study examines 50 cats identified as having pancytopenia in more depth, providing a detailed picture of clinical findings to better understand the disease process in these cats affected by the outbreak.
Records and data of 50 of the affected cats were assessed to identify additional clinical signs which indicated contact with mycotoxins.
Following examination of the cats’ bone marrow, it was found that all cats suffered a marked toxic insult to their bone marrow.
From this, the study concluded that a differential diagnosis of mycotoxin-induced pancytopenia should be considered in cats presenting with pancytopenia.
Lead author of the research, Dr Barbara Glanemann, Senior Lecturer in Small Animal Medicine at the Royal Veterinary College and Co-head of the Small Animal Internal Medicine Service at the RVC’s Queen Mother Hospital for Animals, said:
“These pieces of research involved a great deal of work from many people (noted as authors and acknowledgements in the papers) and we really appreciate the teamwork involved, and the collaborative support we received.
“We know first-hand how much devastation and concern this outbreak caused for many cat owners across the country and so it is our hope that the studies will help people better understand what happened to cause this outbreak and can be used to not only provide some closure to those affected but also reduce the chances of something similar occurring in the future.”
References
The new presentation is honey-flavoured and is available in 30ml or 100ml bottles with a syringe for precise dosing.
It has a two-year shelf life and a broached shelf life of six months.
Dechra companion animal brand manager, Thomas Johnson, said: “The addition of Felimazole Oral to our product range will provide vets with the flexibility to prescribe Felimazole as either a tablet or oral solution to accommodate the preferences of both the cat and its owner.
"This, combined with our extensive endocrinology resources, will ensure that vets have all the necessary tools to support their feline hyperthyroid cases.”
https://www.dechra.co.uk/cushings-connect
https://www.dechra.co.uk/addisons-connect
https://www.dechra.co.uk/search?q=felimazole#/search=Felimazole
https://apps.apple.com/gb/app/dechra-endocrinology-app/id1660737534
Bayer Animal Health has obtained two new licensed indications for its antiparasiticide, Advocate.
The first is that the product is now licensed for the treatment of Crenosoma vulpis using a single dose. The second is that in addition to the existing treatment of Angiostrongylus vasorum claim, Advocate is now indicated for its prevention, using monthly spot-on applications.
This comes at a time when, according to Bayer, independent market research shows that vets are diagnosing Angiostrongylus vasorum at an increasing rate. Figures for 2010 place the incidence of vets who have confirmed cases at 37%, more than double the 16% confirmed in 2008, with a further 19% of vets reporting suspected cases.
Bayer is also stepping up its 'Be Lungworm Aware' consumer campaign, with the addition of a local and national radio campaign throughout October. The public information style advert will warn owners of the dangers associated with the parasite A.vasorum, and urging them to stay vigilant for signs their dog may be infected.
Veterinary staff can also direct clients who wish to learn more about lungworm to http://www.lungworm.co.uk/.
For more information on Advocate, please contact your sales representative or telephone Bayer on 01635 563000.
The offer is timed to coincide with the expected increase in canine pruritis as the warmer weather leads to increased levels of common allergens such as pollen, dust mites and flea bites.
Each practice that buys five packs of Apoquel will get one free, subject to a minimum qualifying purchase.
Apoquel is a fast-acting oral therapy for the treatment of canine pruritus associated with allergic dermatitis.
Zoetis says its novel mechanism of action on the Janus Kinase (JAK) enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
For more information about the Apoquel Spring offer, contact your Zoetis account manager.
The new sections will sit alongside the Emergency and Critical Care (ECC) pages within the Practical and Clinical Skills section of the bank.
Dental subject areas include diagnosis, radiography and surgery. The new exotic subject areas include an overview, birds, small mammals and reptiles. Surgery subject areas include anaesthesia, peri-operative planning, abdominal surgery, ECC/trauma and post-surgical care.
New grad Ellie Morris MRCVS said: "There are some really good videos on emergency surgeries such as the A-Z of GDV, so when we’ve had quieter days I’ve had chance to look at some of these particularly excellent resources and I feel much more prepared for that situation.
"After watching the Anaesthesia of the Caesarean Section webinar, I discussed what I’d learned with my colleagues and how it compared to their approach. I’ve not done a caesarean yet, but I feel a lot more prepared for when the time does come."
BSAVA President Phil Lhermette said: "This fantastic resource is free to all our members with some sections open to non-members - especially employers, and is growing all the time providing great support for the whole profession at every stage of their career.
"The content is reviewed by committee who are currently helping to expand the Mentor & Employer pages, for practices supporting new graduates, which will be added to the site next."
For more information visit: www.bsava.com/pdp
Animalcare says hydrocortisone aceponate is a potent, topical anti-inflammatory, proven to quickly relieve itchy and inflamed skin in dogs.
The new product is applied as a spray, designed to make it easy to target affected areas of skin.
Hydrocortisone Cutaneous Spray Solution is presented in a 76 ml size with a two-year shelf life, six months once opened.
Animalcare Product Manager Eleanor Workman Wright said: “Skin problems are extremely common in dogs.
"They can often cause great discomfort to dogs and concern to their owners.
"We believe that Hydrocortisone Cutaneous Spray Solution will be a useful addition to the range of treatment options currently available to vets as they consider the most appropriate care plan for their patients.”
Thus far, the hospital has relied on conventional radiographs or referred for MRI for the bulk of its distal limb imaging.
The new Hallmarq standing CT scanner provides information that surpasses the capabilities of radiography, while also reducing radiation exposure to the patients and staff.
The scanning process is also considerably quicker, enabling prompt diagnosis and treatment planning.
Tom McParland, Valley Equine Hospital’s surgeon said: "We are confident that this diagnostic modality will significantly enhance our ability to identify not just thoroughbred fetlock pathology earlier but improve our diagnostic abilities of the distal limb for all our equine patients, racing and leisure alike.”
Valley Equine Hospital says it chose the Hallmarq standing CT scanner due to its ability to scan using just standing sedation which ensures a safer and more efficient experience for the horses compared to general anaesthesia.
www.valleyequinehospital.co.ukinfo.hallmarq.net/focus-on-the-foot
The Boehringer Academy (www.boehringer-academy.co.uk) contains hundreds of hours of CPD material on equine, companion and production animals. It comprises a mixture of webinars, podcasts, short videos and downloadable documents, which can be viewed at any time. The site keeps a CPD log for each user and provides downloadable certificates.
Boehringer’s Small Animal Marketing Team Leader, Jemima Mead said: "We already have just over 15,000 vets and nurses in the UK and Ireland currently registered with the Academy.
"New and existing members are eligible to receive the Boehringer Academy colouring book. They simply have to visit www.boehringer-academy.co.uk and complete their profile. In addition, everyone completing their profile will be entered into a draw to win an iPad Pro and Apple Pencil."
The recategorisation means that pharmacists and Suitably Qualified Persons (SQPs) will be able to prescribe Zolvix.
The VMD says that making the anthelmintic more widely available will increase its usage as part of strategic worm control programmes on farms, which could in turn result in long term health benefits for sheep, for example by reducing the development and spread of anthelmintic resistance, thereby prolonging the effective use of anthelmintics.
The VMD adds that SQPs will now have additional training to ensure they are sufficiently familiar with Zolvix and how to prescribe it effectively and responsibly so that it is used appropriately. A new compulsory training module will be implemented by The Animal Medicines Training Regulatory Authority (AMTRA) to augment the skills of all AMTRA-registered SQPs permitted to prescribe farm animal products. New SQPs will be required to undertake a revised and extended module before gaining their farm animal registration with AMTRA.
Pharmacists and SQPs will be able to prescribe Zolvix from 1st July 2017.
UPDATE 16th March:
BVA President Gudrun Ravetz has issued a statement expressing concern over the recategorisation of Zolvix:
"We know that resistance to anthelmintics is increasing in grazing animals and needs to be addressed if the livestock industry is to avoid a potentially disastrous situation of being unable to tackle parasites. The reclassification of Zolvix from POM-V to POM-VPS is in direct opposition to the trend in Europe, where we are seeing increased control over dispensing of anthelmintics in species where resistance is a serious threat to animal welfare and profitable production; we're extremely concerned that we might start seeing resistance develop in group 4 as a result.
"BVA believes that prescribing of anthelmintics requires a level of control best provided by a veterinary surgeon who has the animals under his/her care, and is based on a sound clinical diagnosis, in order to protect animal welfare and safeguard the efficacy of these products for the future."
Further information on BVA's policy on anthelmintics can be found on BVA’s website: www.bva.co.uk/news-campaigns-and-policy/policy/medicines/anthelmintics.
Mr Ng faced seven charges:
Mr Ng admitted some aspects of the charges against him, including that he had deleted two patient records and that this was dishonest and misleading.
The Committee then determined the facts of the rest of the charges after hearing evidence from witnesses and Mr Ng himself, as well as expert witnesses.
Having considered all the evidence, it determined which elements of the charges were proved, and which were not.
The Committee then considered whether the admitted and charges found proved amounted to serious professional misconduct.
In doing so it considered that the charges against Mr Ng fell into three broad categories – deficiencies in clinical care, deficiencies in record keeping, and dishonesty.
In respect of all three, it found the admitted and charges found proved amounted to serious professional misconduct.
In terms of aggravating factors, the Committee found that Mr Ng’s conduct had directly caused harm to animals and also created risk of further harm, and noted that there were three instances of dishonesty.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee noted that there were three instances of dishonest behaviour in relation to clinical records.
"The amendment of the clinical record in the labradoodle’s case was particularly serious.
"This alteration was made at a time when the respondent knew that the owner was dissatisfied with the treatment the dog had received and was complaining about the lack of therapeutic intervention.
"The alteration presented a false account of the owner’s attitude towards immediate therapeutic intervention.
"Conduct of this kind was liable to damage trust in the profession.”
In mitigation, the Committee took into account the sense of pressure Mr Ng felt following a financial dispute with his relative in respect of the veterinary practice, his long career as a veterinary surgeon and the high regard with which he was held by those who provided testimonials on his behalf.
The Committee acknowledged Mr Ng’s assertions that he now understood his failings and his expressions of remorse for the harm he had caused and that these indicated the beginnings of insight.
However, in respect of the clinical deficiencies, the Committee found that various aspects of Mr Ng’s approach to treating conditions such as diabetes and cherry eye were inadequate and out-of-date, and that there was little in his continuing professional development (CPD) record or his statements to suggest he had attempted to improve these deficiencies.
Ultimately, the Committee found that Mr Ng’s conduct was so serious that removal from the Register was the most appropriate sanction.
Paul Morris added: “The Committee has concluded that the respondent’s behaviour was fundamentally incompatible with being a veterinary surgeon.
"In view of the nature and gravity of the Committee’s findings in this case, removal from the Register is necessary to ensure the protection of animals and the maintenance of public confidence in the profession and the regulatory process.”
www.rcvs.org.uk/disciplinary
Mandisa qualified from the Royal (Dick) Vet School in Edinburgh in 2008 and has since spent much of her career working in emergency and critical care.
She served as the first black president of the RCVS in 2020/21 and has also worked for Harper Adams University as a lecturer in veterinary sciences.
Mandisa will replace Laura Playforth, who is joining IVC Evidensia as group QI director, on the Vets Now board.
She said: “I’m delighted to be joining the Vets Now family at such an interesting and challenging time for the veterinary professions.
“I look forward to working together through innovative approaches to ensure our teams continue to deliver the highest standards of clinical care and client services.”
The RCVS has announced that registrations for the new RCVS Register of Veterinary Practice Premises will be accepted from 1 November 2008, allowing all those who wish to supply medicines from veterinary practice premises from 1 April 2009 onwards a full five months to comply with the latest medicines legislation.
In order to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines, the UK Government decided that any veterinary surgeon may only supply veterinary medicinal products (VMPs) from premises registered with the Secretary of State, with effect from 1 April 2009.
The Veterinary Medicines Directorate (VMD) is responsible for the inspection and registration of practices under the Veterinary Medicines Regulations. Steve Dean, VMD's Chief Executive, says the new veterinary practice premises register will complete the UK information base by bringing veterinary practices in line with other suppliers of veterinary medicines who already have to operate from registered premises.
The Register will enable the supply of veterinary medicines by veterinary surgeons, including controlled drugs, to be subjected to inspection and verification. As a result, DEFRA Ministers and the European Commission can be re-assured that veterinary medicines are being supplied in the UK in accordance with EC legislation.
In discussion with the VMD, it was agreed that the most appropriate body to maintain this register would be the RCVS, not least because the College already manages the RCVS Practice Standards Scheme and publishes the (voluntary) Directory of Veterinary Practices, so has the necessary systems already in place. The register will be published on RCVSonline and updated quarterly.
Whilst there will now be a statutory fee levied for each practice premises registered on the new Register, the College's existing database framework has kept this to a relatively low £40 compared to what other bodies might have had to charge after starting from scratch.
Practices could appear in the Directory for free because the cost of producing it was partially covered by subsequent data sales. However, the new Register will need to be self-funding, as the data it contains will be freely available online.
Not all practices will have to pay the statutory fee. RCVS President Jill Nute said: "For those practice premises already accredited under the RCVS Practice Standards Scheme (PSS), the fee will be taken from their existing PSS annual fee.
"What's more, accredited practices will not face additional four-yearly inspections by VMD inspectors (unless there is an investigation for enforcement purposes) as their PSS inspections already ensure that they keep up to date with current medicines legislation."
Practice premises that have applied to join the Scheme, but have not yet been accredited, will not face additional VMD inspections either, but will still need to pay the statutory fee.
To help practices understand the new requirements and what they need to do before next April, the RCVS has produced a range of guidance, including a series of Frequently Asked Questions (www.rcvs.org.uk).
"In particular, we hope this guidance will help to explain which premises are likely to be considered ‘veterinary practice premises' and the difference between those premises and places where medicines might simply be stored or kept," said Mrs Nute.
"It is important to realise that there is a legal requirement to register veterinary practice premises for the supply of medicines, and a professional obligation, set out in the Guide to Professional Conduct, to keep a record of where all medicines are stored or kept. This record should avoid the need for additional registration of car boots, farms and homes."
Over the coming weeks, application forms will be posted to all practices currently listed in the Directory and accredited under the PSS, containing all the practice information currently held. These forms must be checked, signed and returned, even if no fee is due. Separate application forms will be available for any non-accredited practice premises not published in the Directory, and a letter will be sent to all RCVS members to ensure the whole profession is aware of the new requirements.
A study published in the Veterinary Record has shown that Plerion, the broad-spectrum anthelmintic combination preparation for dogs (5 mg pyrantel + 20 mg oxantel + 5 mg praziquantel per kg body weight) is an efficacious and well-tolerated treatment against all important endoparasites, according to manufacturers Intervet Schering-Plough Animal Health.
In addition, because Plerion is formulated as a flavored chewable tablet, the product was readily consumed by the vast majority of dogs.
Although the product has been on the market in the UK since last year, this is the first time that the evidence for its efficacy has been published in the public domain.
Linda Horspool BVMS, PhD, DipECVPT, MRCVS, Global Technical Director Companion Animal Pharmaceuticals at Intervet/Schering-Plough Animal Health said: "Pyrantel, oxantel and praziquantel, the active ingredients of Plerion, are well-established anthelmintics, having been used successfully in humans and animals for decades. The combination of these ingredients in one preparation offers the possibility to eliminate relevant parasites from most dogs in a single treatment. Moreover, the good palatability of the flavored chewable tablets makes Plerion easy to give and helps owners to remember to treat their dogs regularly which contributes to adequate deworming".
The efficacy, safety and palatability of a single-dose treatment with Plerion were assessed after experimental as well as natural infection with common helminths such as whipworms, tapeworms and roundworms. In five controlled studies (48 treated dogs/49 untreated dogs) and three field studies (30 treated dogs), a total of 127 animals were included. In all comparisons, Plerion-treated dogs had statistically significantly lower worm counts than untreated dogs. Moreover, in treated dogs efficacy against whipworms (Trichuris vulpis) was more than 99 percent after experimental infection and 100 percent after natural infection. For roundworms (Toxocara canis), the corresponding figures were 94 and 100 percent, respectively. For tapeworms (Echinococcus granulosus), the efficacy was more than 99 percent after experimental infection.
The preparation was well-tolerated, evidenced by the finding that treatment of dogs with doses up to 6 times the recommended dose or twice the recommended dose on 3 consecutive days did not result in adverse changes in blood parameters, clinical findings or behavior.
In client-owned dogs, Plerion was readily consumed as demonstrated by the fact that 88 percent of dogs spontaneously accepted the tablet. The proportion of spontaneous acceptance appeared higher than the 78 percent that was obtained with another commercially available flavored reference preparation containing pyrantel, febantel and praziquantel.
Worm infestations in dogs are important parasites in terms of prevalence, pathogenicity and, occasionally, zoonotic impact. Therefore, the European Scientific Counsel on Companion Animal Parasites (ESCCAP) has re-emphasized in its 2010 guideline update titled "Worm Control in Dogs and Cats" that veterinarians and pet owners (1) must take measures to protect pets from parasitic infestations, (2) protect the pet population from risks associated with travel and its consequent potential to change local parasite epidemiological situations through the export or import of non-endemic parasite species, and (3) should work together to reduce the risks associated with zoonotic transmission of parasitic diseases.
*ReferenceSchmid K, Rohdich N, Zschiesche E, Kok DJ, Allan MJ. Efficacy, safety and palatability of a new broad-spectrum anthelmintic formulation in dogs. Veterinary Record 2010;167:647-651
Invicta Animal Health has launched SynVet-50, a licensed synthetic Sodium Hyaluronate (HA), for intra-articular treatment of lameness caused by joint dysfunction associated with non-infectious synovitis in horses.
The product is Invicta's first licensed medicine.
According to the company, the functional mechanisms of HA are directly dependent on the molecular weight and concentration of HA. 1 Therefore, SynVet-50 has been formulated with a molecular weight of 1.5m Daltons which is the highest of any synthetic HA available in the UK.
Invicta says that at 20mg per ml, SynVet-50 is also the most concentrated HA available.
Storage is at ambient temperature.
SynVet-50 is a 2.5ml solution containing 50mg HA, conveniently presented in a 5ml glass syringe.
Rob Watkins, Managing Director of Invicta said: "We are excited to be launching our first licensed medicine in the UK. The management team of Invicta have over 10 years experience in this market which has allowed us to provide a product strongly focussed on the clinicians needs, not just in terms of technical ability, but also in convenience of presentation".
For further information see www.invictavet.com or phone 01403 791313
Reference
The RCVS has published Fitness to Practise - A Guide for UK Veterinary Schools and Veterinary Students, a guide for veterinary students which aims to introduce them to the concept of fitness to practise and help prepare them for professional life.
The guide was developed by an RCVS working party in conjunction with the UK's seven veterinary schools that currently offer an RCVS-approved veterinary degree. It has also received approval from the Veterinary Schools Council, a new body which represents the interests of the country's veterinary schools.
The guide is split into two parts: the first part provides guidance for veterinary schools on how to recognise and address fitness to practise concerns; the second part sets out the broad principles of fitness to practise that students should follow and which veterinary schools should uphold.
Laura McClintock, an Advisory Solicitor from the RCVS Professional Conduct Department, said: "While we don't regulate veterinary students themselves, we hope that this guidance will prepare future vets for the requirements and standards that we expect from members of a regulated profession and for adhering to our Code of Professional Conduct and its supporting guidance.
"The guide also recognises that each university will have its own specific disciplinary guidelines and procedures, but we hope that this will help promote consistency in their fitness to practise regimes.
"Although we expect any adverse findings made in university fitness to practise proceedings to be declared to us upon application to register, we would take into account the fact that a student is not a fully-fledged professional and would therefore make some allowance for any mistakes and poor judgement when considering whether or not they should join the Register."
The guide can be downloaded for free from www.rcvs.org.uk/studentguide
The RCVS is also in the process of forming a working party to produce equivalent guidance for student veterinary nurses.
The research, carried out by the Royal Veterinary College’s (RVC) VetCompass programme, involved analysing data from 333,910 bitches who presented at veterinary practices participating in the programme between 2014 and 2017.
The study also indicated that the females of certain breeds are more prone to UI than others, with Hungarian Vizslas, Doberman, Weimaraners and Boxers most at risk.
UI affects around 3% of bitches in primary veterinary care in England.
The researchers say that a connection between neutering and UI in bitches has long been suspected but this study provides stronger evidence on the extent of the relationship.
The data also showed that age and bodyweight are major contributory factors to bitches developing UI as well as neutering and breed. Other key findings include:
Bitches over nine years old are 1.7 times more likely to develop UI compared to those younger than three years.
Bitches weighing over 10kg are 1.9 more likely to develop UI than those weighing less than 10kg, while bitches over 30kg are three times more likely.
Camilla Pegram, VetCompass epidemiologist and lead researcher on the study, said: "First opinion vets discuss and perform neuters on a daily basis but, until now, evidence on the link between neutering and urinary incontinence has been tenuous.
"This study provides stronger evidence of an important association between neutering and urinary incontinence. The decision to neuter a bitch is based on many factors, not just incontinence risk alone. However, these results suggest that the component of the decision driven by urinary incontinence could be emphasised for the high-risk breeds and bitches of larger bodyweight.”
It is hoped that the results will aid owners and vets in making evidence-based decisions when it comes to neutering female dogs.
The College says the online library, which is free to access, aims to encourage people to develop their leadership skills, regardless of what stage of their career they are at.
The Library has a range of materials that learners can work through at their own pace, including presentations, interviews, videos, blogs, articles and webinars on key leadership topics such as Delegation Skills, Difficult Conversations and Inclusive Leadership.
The RCVS Leadership Team will be adding more content to the library, and the profession will have opportunities to suggest topics that they would like to learn more about.
Gurpreet Gill, RCVS Leadership and Inclusion Manager, said: “In terms of veterinary CPD, importance often tends to be placed more on clinical and technical capabilities, but leadership skills are a critical aspect of every veterinary practice and organisation.
“It is also assumed that leadership is a condition of status or position, but this is not necessarily the case.
"Leadership is an everyday practice that is applicable to everyone, regardless of their role.
"The Leadership Library provides learning opportunities for anyone looking to develop and reflect on their leadership skills, which will also count towards the annual CPD requirement.”
The Leadership Library can be accessed now from https://www.rcvs.org.uk/lifelong-learning/rcvs-leadership-initiative/rcvs-leadership-library/
Mrs Cole pleaded guilty to fraud in July 2024 at Crawley Magistrates’ Court and was sentenced to eight months in prison suspended for 12 months, 20 days rehabilitation activity and a £187 victim surcharge.
The College opened its own disciplinary investigation against Mrs Cole after receiving the certificate of conviction, which related to more than £13,000 of pet insurance fraud.
It then proceeded with the hearing in Mrs Cole’s absence as she had not responded to any of the communications sent to her by the College on the matter.
Having found the charge against her proven by the certificate of conviction, the Committee then determined that the conviction amounted to serious professional misconduct.
Dr Kathryn Peaty MRCVS, chairing the committee and speaking on its behalf, said: “The respondent’s conduct… was plainly dishonest and contravened a fundamental tenet of the profession.
"She abused her professional position in order to commit the offence.
"The dishonest conduct in this case related directly to the respondent’s professional life, as she was working as a veterinary nurse when she completed and submitted the fraudulent claims.
“Her conduct also constituted a breach of the trust owed to her employer and to the insurance company to which her dishonest claims were submitted.
"She put her professional colleagues at risk as their names were used on the clinical records which purportedly supported her dishonest claims.
“Her misconduct was repeated and sustained over a period of many years.
"Her modus operandi was sophisticated and premeditated.
“The respondent’s conduct clearly had the potential to bring the profession into disrepute and to undermine public trust in the profession.
"A member of the public would be rightly appalled to learn that a veterinary nurse had abused her position by submitting false claims in this way.”
The Committee found that there were no mitigating factors, and that aggravating factors included the premeditated nature of Mrs Cole’s fraud, the clear breaches of trust in respect of her colleagues, her clients and the insurance companies, the significant financial gain made from her fraud and the fact that the fraudulent activities were sustained and repeated over a period of four and a half years.
Kathryn added: “Taking into account the gravity of her misconduct, the need to maintain standards of probity in the profession, especially in relation to practice records and the submission of insurance claim documents, as well as the maintenance of public confidence in the profession, the Committee has resolved to direct the Registrar to remove the respondent’s name from the Register.
Global names in gastroenterology will be sharing the latest knowledge to help veterinary surgeons and nurses support the work of the BHS and Nottingham University’s REACT to colic campaign, which is designed to help vets and horse owners work together for colic patients.
On Friday 13th September there'll be a two-hour session chaired by Harry Carslake, a diplomate of the American College of Veterinary internal medicine (ACVIM). The session will involve five experts speaking about aspects of colic, followed by discussion and the opportunity for questions from delegates.
Natasha Jocelyn, Internal Medicine Specialist, Sussex Equine Hospital, will speak about managing the acute colic in the field: what to do when flunixin doesn’t work.
Prof. Dr. Gunther Van Loon European Veterinary Specialist in Equine Internal Medicine, Ghent University, Belgium, will discuss managing acute colic in the equine hospital.
Dr Nathan Slovis member of the American College of Internal Veterinary Medicine, Director of the McGee Medicine Department and a partner at Haygard Equine Medical Institute in Lexington, Ky will explain colic guidelines – can ‘algorithms’ help?
Prof. Dr Lutz Goehring European Veterinary Specialist in Equine Internal Medicine, Ludwig-Maximilians University Munich, will explore the question ‘is there an evidence-based approach to managing enteritis?’
David Rendle European Veterinary Specialist in Equine Internal Medicine, Rainbow Equine Hospital, North Yorkshire, will look at parasitic disease as a cause of colic and methods of management.
All BEVA Congress delegates get a certificate of attendance worth seven hours of CPD.
If you're struggling for time or torn between several lectures you can use the BEVA Congress Encore Room to play back missed lectures at your convenience. BEVA Congress is also providing day crèche for children between the ages of 0-8 years. Find out more here.
Anyone who registers for Congress before 8 May 2019 will receive significantly reduced booking fees, and BEVA members save up to £379 on their Congress passes.
At the heart of the campaign is a website - www.beatdogheartdisease.co.uk - where dog owners can learn more about mitral valve disease and dilated cardiomyopathy, find out which breeds are most at risk and read more about the diagnosis and management of canine heart disease.
Boehringer has also created a Facebook page - www.facebook.com/beatcanineheartdisease - offering regular updates on heart health and a platform for owners to share their stories. Owners can also use the ‘Love Your Dog’s Heart’ Facebook profile frame to help spread awareness of the disease.
The aim of the campaign is to get pet owners thinking about mitral valve disease and having it treated whilst it is still in the asymptomatic phase, in order to slow the disease progression and delay the onset of heart failure1.
Vetmedin practices can access additional ‘Love Your Dog’s Heart’ campaign materials via the Boehringer Ingelheim Resource Hub at boehringer-ingelheim-resourcehub.co.uk.
The brainchild of Sonya Miles CertAVP(ZM), CertAqV, MRCVS, Just Exotic (www.justexotics.co.uk) offers a range of training webinars, fact sheets, care sheets and ‘how to’ videos developed for veterinary surgeons, nurses and students. The webinars cost between £15 and £55 (depending on the length), and include presentations by Sonya herself, Eliabetta Mancinelli, Agata Witkowska, Louise Ash, Sarah Pellett and others.
Sonya said: “We’ve developed our content to be convenient and affordable. Some of it may also be helpful for clients.
"More content will be added on a regular basis, and please, if there is something you specifically want covered, drop us a line to info@justexotics.co.uk and will we do our best to make sure it becomes available.”
The fellowship provides a grant of up to £35,000 for work in companion animal research to be spent over a maximum of two years.
Applications are open to veterinary surgeons who have completed a postgraduate qualification such as a PhD or Masters, and who are within the first four years after starting an academic post (Lecturer, Fellowship or above) and have received no more than £50,000 of funding in competitive external grants to date.
David Killick, Chair of the BSAVA PetSavers Grants Awarding Committee said: “BSAVA PetSavers is delighted to launch the PetSavers Research Fellowship.
"It is well recognised that the journey from completion of a PhD to becoming established as an independent researcher is one of the most challenging times of a researcher career.
“With this new grant BSAVA PetSavers will support exceptional veterinary professionals in the Early Career Researcher phase develop their research ideas by providing £35,000 towards research costs over a two-year period.
"Through this initiative BSAVA PetSavers aims to help these researchers reach their potential and in so doing expand the capacity for companion animal research in the UK.”.
Applications close on 28th February 2022, and a decision will be made by the end of May 2022.
To apply for the Research Fellowship, visit the BSAVA PetSavers website: https://www.petsavers.org.uk/Apply-for-funding/research-fellowship
In 2022, Winchester published the results of a study led by Professor Andrew Knight, which claimed the headline: "Vegan diets may be the healthiest to feed pet dogs, say researchers"1,2.
For the study, 2,639 dog owners were invited to report their own opinion of seven indicators of their dog's health.
The researchers also looked at the prevalence of 22 specific health disorders, reported as being based on 'predictions by vet assessments', finding 49% prevalence in traditional meat diets, 43% for raw meat diets and 36% for vegan diets.
However, it was not clear in the report what "predictions by vet assessments" actually means. Whose predictions? The vets'? Or the owners'?
Closer examination of the original study reveals it was "owners' predictions of vet assessments".
Owner-reported opinion, otherwise known as anecdote, is of course notoriously unreliable, and if there is one thing more unreliable than owner-reported opinion, it would surely be owner-reported opinion of their vet's opinion.
Furthermore, the original study was of an observational design, and therefore could only suggest correlation, not causation.
Lastly, the original analysis only looked at the relationship between diet and owner observations/opinion, without considering the impact of other factors assessed by the study, such as the age of the dog and whether the owner was a vegan.
For the new study3, therefore, researchers at the University of Liverpool led by Professor Alex German re-analysed the data used for the original study, in particular correcting the data for confounding variables.
When analysed in this way, significant illness in dogs correlated most strongly with the age of the dog, whether it was on medication, and the frequency of visit to the vet.
Compared to these, the association between owner opinions of health and feeding vegan dog food was minimal.
Co-author of the second study, Richard Barrett-Jolley, Professor of Neuropharmacology, said: “We know how seriously owners take their pet’s health.
"By revisiting and further interrogating these data, we have been able to draw more nuanced insights. “Crucially, we cannot draw a firm conclusion as to what diet type is actually best for dogs; this was never possible given the nature of the original dataset and study design.
"However, we can conclude that variables other than dog diet are more strongly associated with owner opinions about the health of their dog.”
Virbac Animal Health is offering practices an educational shampoo and skin care pack for pet owners.
The pack is free to practices that buy any 12 shampoos from the Virbac range. In return the practice will receive a range of educational and point of sale materials, including a counter display unit and 'give away' hand sanitisers. Each practice also receives 2 free shampoos and a bottle of either Humilac or Dermacool FOC.
According to the company, the idea behind the initiative is to help pet owners understand the importance of bathing their pets, and of correct product selection.
Product manager Chris Geddes MRCVS said: "We also hope that it will assist vets and VNs to easily identify the correct product for every type of skin.
"The colour-coordinated packaging and literature contains easy-to-follow advice for pet owners and vet staff. And with all the extra items, we believe the promotion is great value for money."
Chris also believes the pack will help pet owners to understand the importance of regular and correct bathing: "Many owners just accept that their pet smells, without realising that this shouldn't be the case. This is the 'doggy' smell that many owners accept as normal."
"Also, many owners who do bathe their pets use soaps or shampoos from their own bathroom, not knowing that these are totally unsuitable for animals. Hopefully this promotion will help pet owners understand why it is important to use specifically formulated products for their pet."
The promotion runs until the end of July. Those interested in the pack please contact your Virbac territory manager or call the company on 01359 243243.
Intervet /Schering-Plough Animal Health has announced plans for a third National Vaccination Month Campaign to take place in May.
The campaign, which is aimed at owners of unvaccinated animals, is being fronted by TV presenter and wildlife expert Chris Packham. Intervet / Schering-Plough says it hopes the initiative will counter falling rates of pet vaccination that have been seen since the credit crunch.
In the lead up to National Vaccination Month, the company will be running a pet health awareness national and regional PR campaign backed up by print and TV advertising.
Pet owners will be able to download a voucher for a discounted vaccination in May from http://www.nvmonline.co.uk/. As well as dogs, cats and rabbits, horses will be included in the scheme for the second time.
During the last National Vaccination Month in June 2009, 1022 surgeries participated nationwide and an additional 40,000 animals were vaccinated as a result - 8,000 up on the first campaign run in 2008. According to Intervet / Schering-Plough, many practices saw more than 100 vouchers being redeemed.
The 2009 campaign came after more than a quarter of vets surveyed by Intervet reported concerns about falling levels of vaccination because of the credit crunch. Following the recession and public fears over the deficit, there are concerns that pet owners will cut back even further.
Angus Robinson from Intervet / Schering-Plough Animal Health said: "Research shows that the main reason why people don't vaccinate their pets is a lack of awareness of disease risk. We are also concerned that given the current pressures on household budgets, more people are deciding to cut back on vaccinating their animals with the real risk that this may have a potential effect on levels of herd immunity in the longer term."
He added: "We listened to practices which took part in NVM 2009 and have invested in improving the website to offer a simpler system for surgeries to download and log vouchers for their clients. The site will also drive pet owners to participating vets more quickly. Social media has taken off in a big way since our first campaign in 2008 and we will also be using Facebook and Twitter this time to reflect that. We are hoping that this will reach younger pet owners as data from our last campaign showed that pet owners in their 20s and early 30s were the age group least likely to vaccinate their animals."
Jane Carter of the Drove Veterinary Hospital in Swindon said: "National Vaccination Month is a golden opportunity to communicate the key preventative healthcare messages to new and existing clients. There was a significant outbreak of parvovirus in our area last summer which got a lot of publicity so we are expecting people will really catch onto the campaign this time."
Intervet / Schering-Plough Animal Health veterinary customers planning to take part in National Vaccination Month 2011 can log onto www.nvmonline.co.uk to complete the registration process.